Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life

Parkinsonism and Related Disorders

Volumn 20, Issue 10, 2014, Pages 1071-1075

  Lawson, Rachael A ^a   Yarnall, Alison J ^a   Duncan, Gordon W ^a   Khoo, Tien K ^b   Breen, David P ^c   Barker, Roger A ^c   Collerton, Daniel ^a   Taylor, John Paul ^a   Burn, David J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Mild cognitive impairment; Parkinson's disease; Quality of life

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL PRACTICE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; FEMALE; GERIATRIC DEPRESSION SCALE; HOEHN AND YAHR SCALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; QUALITY OF LIFE; SLEEP; UNIFIED PARKINSON DISEASE RATING SCALE; VERY ELDERLY; ATTENTION; COMPLICATION; DEPTH PERCEPTION; EXECUTIVE FUNCTION; MEMORY; NONPARAMETRIC TEST; PREDICTIVE VALUE; PSYCHOLOGY;

AGED; ATTENTION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; SPACE PERCEPTION; STATISTICS, NONPARAMETRIC;

EID: 84908130426     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.07.004     Document Type: Article

References (30)

1. Leroi I., McDonald K., Pantula H., Harbishettar V. Cognitive impairment in parkinson disease: impact on quality of life, disability, and caregiver burden. JGeriatr Psychiatry Neurol 2012, 25:208-214.
2. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disorders Official Journal Mov Disord Soc 2007, 22:1689-1707.
3. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disorders Official Journal Mov Disord Soc 2008, 23:837-844.
4. Litvan I., Goldman J.G., Tröster A.I., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Disorders Official Journal Mov Disord Soc 2012, 27:349-356.
5. Williams-Gray C.H., Evans J.R., Goris A., Foltynie T., Ban M., Robbins T.W., et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain A Journal Neurology 2009, 132:2958-2969.
6. Broeders M., de Bie R.M., Velseboer D.C., Speelman J.D., Muslimovic D., Schmand B. Evolution of mild cognitive impairment in Parkinson disease. Neurology 2013, 81:346-352.
7. Janvin C.C., Larsen J.P., Aarsland D., Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disorders Official Journal Mov Disord Soc 2006, 21:1343-1349.
8. Reginold W., Duff-Canning S., Meaney C., Armstrong M.J., Fox S., Rothberg B., et al. Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dement Geriatr Cogn Disord 2013, 36:67-75.
9. Yarnall A.J., Rochester L., Burn D.J. Mild cognitive impairment in Parkinson's disease. Age Ageing 2013, 24:567-576.
10. Kehagia A.A., Barker R.A., Robbins T.W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010, 9:1200-1213.
11. Hurt C.S., Landau S., Burn D.J., Hindle J.V., Samuel M., Wilson K., et al. Cognition, coping, and outcome in Parkinson's disease. Int Psychogeriatr 2012, 24:1656-1663.
12. Bronnick K., Ehrt U., Emre M., De Deyn P.P., Wesnes K., Tekin S., et al. Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. JNeurol Neurosurg Psychiatr 2006, 77:1136-1142.
13. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatr 1992, 55:181-184.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
15. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. JAm Geriatr Soc 2005, 53:695-699.
16. Nicholl C.G., Lynch S., Kelly C.A., White L., Simpson P.M., Wesnes K.A., et al. The cognitive drug research computerized assessment system in the evaluation of early dementia-is speed of the essence?. Int J Geriatr Psychiatry 1995, 10:199-206.
17. Robbins T.W., James M., Owen A.M., Sahakian B.J., McInnes L., Rabbitt P. Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994, 5:266-281.
18. Tombaugh T.N., Kozak J., Rees L. Normative data stratified by age and education for two measures of verbal Fluency: FAS and animal naming. Arch Clin Neuropsychol 1999, 14:167-177.
19. Ala T.A., Hughes L.F., Kyrouac G.A., Ghobrial M.W., Elble R.J. Pentagon copying is more impaired in dementia with lewy bodies than in Alzheimer's disease. JNeurol Neurosurg Psychiatr 2001, 70:483-488.
20. Jenkinson C., Fitzpatrick R.A.Y., Peto V.I.V., Greenhall R., Hyman N. The Parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997, 26:353-357.
21. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., et al. Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord Official Journal Mov Disord Soc 2008, 23:2129-2170.
22. Mathias J.L., Bowden S.C., Barrett-Woodbridge M. Accuracy of the wechsler test of adult reading (WTAR) and national adult reading test (NART) when estimating IQ in a healthy Australian sample. Aust Psychol 2007, 42:49-56.
23. Yesavage J.A., Sheikh J.I. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986, 5:165-173.
24. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., Gornbein J. The neuropsychiatric inventory. Neurology 1994, 44:2308.
25. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disorders Official Journal Mov Disord Soc 2010, 25:2649-2653.
26. Klepac N., Trkulja V., Relja M., Babic T. Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol Official Journal Eur Fed Neurol Soc 2008, 15:128-133.
27. Kudlicka A., Clare L., Hindle J.V. Quality of life, health status and caregiver burden in Parkinson's disease: relationship to executive functioning. Int J Geriatr Psychiatry 2014, 29:68-76.
28. Trigg R., Watts S., Jones R., Tod A. Predictors of quality of life ratings from persons with dementia: the role of insight. Int J Geriatr Psychiatry 2011, 26:83-91.
29. Schrag A., Hovris A., Morley D., Quinn N., Jahanshahi M. Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov Disorders Official Journal Mov Disord Soc 2003, 18:1250-1256.
30. Pfeiffer H.C., Lokkegaard A., Zoetmulder M., Friberg L., Werdelin L. Cognitive impairment in early-stage non-demented Parkinson's disease patients. Acta Neurol Scand 2014, 129:307-318.